INFLUENCE OF NANOPARTICLES ON THERMAL STABILITY OF ASPARTATE AMINOTRANSFERASE
DOI:
https://doi.org/10.54361/ljmr.v14i1.04Keywords:
Au, TiO2, Fe3O4, nanoparticles, aspartate aminotransferase, thermoinactivationAbstract
For the first time, the complex study of influence of gold, titan dioxide and magnetite nanoparticles on the catalytic properties, thermo-inactivation and aggregation of oligomeric enzyme was performed on the example of aspartate aminotransferase. It has been established that coating of nanoparticles with dextran sulphate contributed to the increase of thermostability of mAspAT, which was observed at 60 0C and higher. The antiaggregation strength of nanoparticles can be ranged as follows: TiO2 NP > Au NPs > Fe3O4 NPs. The aim of the research - comparative study of the kinetic of thermal inactivation of mitochondrial aspartate aminotransferase (mAspAT) in the presence of native and dextran sulfate-modified TiO2 and Fe3O4 nanoparticles (NP). Both, native and dextran sulphate-modified NPs showed the strongest thermal protection at 60 0С and above. The thermal inactivation rate constant (kin) of mAspAT was significantly decreased in the presence of NP-TiO2. Modification of NP surface with dextran sulphate enhanced that effect. Magnetite NP had revealed lower thermal protecting properties. Structural stability of mAspAT in the presence of NPs was characterized by the following thermodynamic parameters: Еаin (inactivation energy), ∆H (enthalpy), and ∆S (entropy) and ∆G (Gibbs free energy). In conclusion, interaction between mAspAT and NPs leads to increase of conformational rigidity of the enzyme and depends mainly on the nature of NP. Stability of gold colloid nanoparticles (Au NPs) is dependent on many factors like buffer concentration and pH values of medium, as well the recombinant AspAT can protect gold colloid nanoparticles from aggregation caused by influence of acidity of buffer or medium
References
Yu X, et al. (2016) Design of nanoparticle-based carriers for targeted drug delivery. J Nanomaterials. 15: 2016. DOI: https://doi.org/10.1155/2016/1087250
Yin J, et al (2016) Stimuli-responsive block copolymer-based assemblies for cargo delivery and theranostic applications. Polymers: 8 (7): 268. DOI: https://doi.org/10.3390/polym8070268
Siegler EL, et al (2016) Nanomedicine targeting the tumor microenvironment: therapeutic strategies to inhibit angiogenesis, remodel matrix, and modulate immune responses. J Cellular Immunother. 2(2): 69 – 78. DOI: https://doi.org/10.1016/j.jocit.2016.08.002
Werner M, et al. (2018) Nanomaterial interactions with biomembranes: bridging the gap between soft matter models and biological context. Biointerphases. 3(2): 028501. DOI: https://doi.org/10.1116/1.5022145
Ventola CL (2017) Progress in nanomedicine: approved and investigational nanodrugs,” Pharmacy and Therapeutics. 42(12): 742 – 755.
Tran S, et al. (2017) “Cancer nanomedicine: a review of recent success in drug delivery,” Clinical and Translational Medicine. 6(1): 44. DOI: https://doi.org/10.1186/s40169-017-0175-0
Souery WN, Bishop CJ (2018) Clinically advancing and promising polymer-based therapeutics. Acta Biomaterialia. 67(1): 20. DOI: https://doi.org/10.1016/j.actbio.2017.11.044
Ma X, Zhao Y (2015) Biomedical applications of supramolecular systems based on host–guest interactions. Chem Reviews. 115(15): 7794 – 7839. DOI: https://doi.org/10.1021/cr500392w
Barra D. et al. (1976) Large-scale purification and some properties of the mitochondrial aspartate aminotransferase from pig heart. Eur. J. Biochem. 64(23):519–526. DOI: https://doi.org/10.1111/j.1432-1033.1976.tb10331.x
Karmen A. (1955) A note on spectrometric assay of glutamic oxalacetic transaminase. J. Clin. Invest. 34:131-133. DOI: https://doi.org/10.1172/JCI103055
Golub N. et al. (2008) Thermal inactivation, denaturation and aggregation of mitochondrial aspartate aminotransferase. Biophys. Chem. 135:125-131. DOI: https://doi.org/10.1016/j.bpc.2008.04.001
Lombardo D (2015) Amphiphiles self-assembly: basic concepts and future perspectives of supramolecular approaches. Advances in Condensed Matter Physics. 22:2015. DOI: https://doi.org/10.1155/2015/151683
Wang J, Li S, Han Y, et al. (2018) Poly(ethylene glycol)–polylactide micelles for cancer therapy. Frontiers in Pharmacol. 9:202. DOI: https://doi.org/10.3389/fphar.2018.00202
Xiue J, et al. (2005) Cytochrome c superstructure biocomposite nucleated by gold nanoparticle: thermal stability and voltammetric behavior. Biomacromolecules. 6: 3030 –3036. DOI: https://doi.org/10.1021/bm050345f
Ding D, Zhu Q (2018) Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics. Materials Science and Engineering: C. 92: 1041–1060. DOI: https://doi.org/10.1016/j.msec.2017.12.036
Bodratti A and Alexandridis P (2018) Formulation of poloxamers for drug delivery. J Functional Biomaterials. 9(1): 11. DOI: https://doi.org/10.3390/jfb9010011
Quiñones JP, Peniche H, Peniche C (2018) Chitosan based self-assembled nanoparticles in drug delivery. Polymers. 10 (3): 235. DOI: https://doi.org/10.3390/polym10030235
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Abdulati El Salem, Waleed R A Abusittah, Mahmud El Abushhewa (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
